INSULIN HYPERSECRETION - A DISTINCTIVE FEATURE BETWEEN ESSENTIAL AND SECONDARY HYPERTENSION

被引:54
作者
SECHI, LA
MELIS, A
TEDDE, R
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143
[2] UNIV SASSARI,INST CLIN MED GEN,I-07100 SASSARI,ITALY
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1992年 / 41卷 / 11期
关键词
D O I
10.1016/0026-0495(92)90019-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several studies have demonstrated that patients with hypertension have greater plasma insulin levels than normotensive subjects. The aim of the present study was to clarify if hyperinsulinemia in hypertension is a consequence of either increased pancreatic secretion or decreased hepatic clearance, and to determine whether abnormalities of glucose metabolism are equally present in essential and secondary hypertension. In an observational cross-sectional study, fasting blood glucose, plasma insulin, and plasma C-peptide levels were measured in five patient groups: 34 lean normotensive, 19 overweight normotensive, 25 lean essential hypertensive, 27 overweight essential hypertensive, and 20 secondary hypertensive subjects. The blood glucose/plasma insulin and plasma insulin/plasma C-peptide ratios were calculated as indexes of insulin sensitivity and hepatic insulin clearance, respectively. Subjects with essential hypertension and, to a greater extent, those who were overweight, exhibited significantly higher fasting insulin and C-peptide levels and significantly lower glucose/insulin ratios as compared with lean normotensive subjects. In contrast, no differences were observed between secondary hypertensive and control subjects. Mean blood pressure was significantly and independently correlated to body mass index, plasma insulin and plasma C-peptide levels, and the glucose/insulin ratio. In lean essential hypertensive and secondary hypertensive subjects, the insulin/C-peptide ratios were comparable to controls, indicating normal hepatic insulin clearance. In both overweight groups, a trend to increased insulin/C-peptide ratios was observed. This study shows that in essential hypertensive subjects, hyperinsulinemia is caused by insulin hypersecretion, whereas in overweight subjects, both increased insulin secretion and decreased hepatic insulin clearance might be involved. The absence of hyperinsulinemia in subjects with secondary hypertension indicates that this abnormality is not induced by high blood pressure, per se, but is associated only with essential hypertension, and may be implicated in the pathophysiology of this disease. © 1992.
引用
收藏
页码:1261 / 1266
页数:6
相关论文
共 38 条
[1]   THE EFFECT OF GROWTH-HORMONE ON GLUCOSE-METABOLISM AND INSULIN-SECRETION IN MAN [J].
BRATUSCHMARRAIN, PR ;
SMITH, D ;
DEFRONZO, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (05) :973-982
[2]  
CHRISTLIEB AR, 1985, HYPERTENSION, V7, P54
[3]  
DEFRONZO RA, 1981, DIABETOLOGIA, V21, P165, DOI 10.1007/BF00252649
[4]  
FABER OK, 1981, J CLIN ENDOCR METAB, V53, P618, DOI 10.1210/jcem-53-3-618
[5]   KINETICS OF HUMAN CONNECTING PEPTIDE IN NORMAL AND DIABETIC SUBJECTS [J].
FABER, OK ;
HAGEN, C ;
BINDER, C ;
MARKUSSEN, J ;
NAITHANI, VK ;
BLIX, PM ;
KUZUYA, H ;
HORWITZ, DL ;
RUBENSTEIN, AH ;
ROSSING, N .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (01) :197-203
[6]   INSULIN RESISTANCE IN ESSENTIAL-HYPERTENSION [J].
FERRANNINI, E ;
BUZZIGOLI, G ;
BONADONNA, R ;
GIORICO, MA ;
OLEGGINI, M ;
GRAZIADEI, L ;
PEDRINELLI, R ;
BRANDI, L ;
BEVILACQUA, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (06) :350-357
[7]  
Ferrannini E, 1989, J NEPHROL, V1, P3
[8]   INSULIN, INSULIN SENSITIVITY AND HYPERTENSION [J].
FERRARI, P ;
WEIDMANN, P .
JOURNAL OF HYPERTENSION, 1990, 8 (06) :491-500
[9]   BLOOD-PRESSURE, INSULIN, AND GLYCEMIA IN NONDIABETIC SUBJECTS [J].
FOURNIER, AM ;
GADIA, MT ;
KUBRUSLY, DB ;
SKYLER, JS ;
SOSENKO, JM .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (05) :861-864
[10]  
HILTON PJ, 1986, NEW ENGL J MED, V314, P222, DOI 10.1056/NEJM198601233140407